New! View global litigation for patent families

WO2017060750A1 - Use of a withania extract for the treatment of demyelinating deseases - Google Patents

Use of a withania extract for the treatment of demyelinating deseases

Info

Publication number
WO2017060750A1
WO2017060750A1 PCT/IB2015/001979 IB2015001979W WO2017060750A1 WO 2017060750 A1 WO2017060750 A1 WO 2017060750A1 IB 2015001979 W IB2015001979 W IB 2015001979W WO 2017060750 A1 WO2017060750 A1 WO 2017060750A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
composition
extract
ms
plant
withania
Prior art date
Application number
PCT/IB2015/001979
Other languages
English (en)
French (fr)
Inventor
Chérif RABHI
Léon Cariel
Jamal Ouazzani
Guillaume ARCILE
Original Assignee
Ethnodyne
Centre National De La Recherche Scientifique (Cnrs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
PCT/IB2015/001979 2015-10-05 2015-10-05 Use of a withania extract for the treatment of demyelinating deseases WO2017060750A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/001979 WO2017060750A1 (en) 2015-10-05 2015-10-05 Use of a withania extract for the treatment of demyelinating deseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/001979 WO2017060750A1 (en) 2015-10-05 2015-10-05 Use of a withania extract for the treatment of demyelinating deseases

Publications (1)

Publication Number Publication Date
WO2017060750A1 true true WO2017060750A1 (en) 2017-04-13

Family

ID=54697611

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/001979 WO2017060750A1 (en) 2015-10-05 2015-10-05 Use of a withania extract for the treatment of demyelinating deseases

Country Status (1)

Country Link
WO (1) WO2017060750A1 (it)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110230551A1 (en) * 2008-09-15 2011-09-22 Leslie Gunatilaka Withaferin a analogs and uses thereof
WO2014202469A1 (fr) 2013-06-17 2014-12-24 Ethnodyne Procede d'obtention d'un extrait de plante et compositions associees

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110230551A1 (en) * 2008-09-15 2011-09-22 Leslie Gunatilaka Withaferin a analogs and uses thereof
WO2014202469A1 (fr) 2013-06-17 2014-12-24 Ethnodyne Procede d'obtention d'un extrait de plante et compositions associees

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BRADL. M.; H. LASSMANN., ACTA NEUROPATHOL, vol. 19, 2010, pages 37 - 53
CHARLES ET AL., PNAS, vol. 97, 2000, pages 7585 - 7590
CHÉRIF RABHI ET AL: "Antiangiogenic-Like Properties of Fermented Extracts of Ayurvedic Medicinal Plants", JOURNAL OF MEDICINAL FOOD, vol. 18, no. 9, 1 September 2015 (2015-09-01), US, pages 1065 - 1072, XP055250185, ISSN: 1096-620X, DOI: 10.1089/jmf.2014.0128 *
CHIHIRO TOHDA: "ChemInform Abstract: Overcoming Several Neurodegenerative Diseases by Traditional Medicines - The Development of Therapeutic Medicines and Unraveling Pathophysiological Mechanisms", CHEMINFORM, vol. 39, no. 52, 23 December 2008 (2008-12-23), DE, pages 1159 - 1167, XP055250168, ISSN: 0931-7597, DOI: 10.1002/chin.200852253 *
GEETA MAKER-CLARK ET AL: "Integrative therapies for multiple sclerosis", DISEASE-A-MONTH., vol. 59, no. 8, 1 August 2013 (2013-08-01), US, pages 290 - 301, XP055250173, ISSN: 0011-5029, DOI: 10.1016/j.disamonth.2013.03.017 *
NAKAYAMA ET AL: "Withanoside IV improves hindlimb function by facilitating axonal growth and increase in peripheral nervous system myelin level after spinal cord injury", NEUROSCIENCE RESEARCH, ELSEVIER, SHANNON, IR, vol. 58, no. 2, 1 June 2007 (2007-06-01), pages 176 - 182, XP022100926, ISSN: 0168-0102, DOI: 10.1016/J.NEURES.2007.02.014 *

Similar Documents

Publication Publication Date Title
Peng et al. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model
Bianchi et al. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome
US6165515A (en) Method for treatment of osteoporosis
US5013558A (en) Pharmaceutical treatments for cerebral and neuronal diseases
Deckwerth et al. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis)
Honegger et al. Nerve growth factor (NGF) stimulation of cholinergic telencephalic neurons in aggregating cell cultures
Bähr et al. Astrocytes from adult rat optic nerves are nonpermissive for regenerating retinal ganglion cell axons
Villeneuve et al. Estrogens in tardive dyskinesia in male psychiatric patients
Ring et al. Prolongation of skin allografts in rats by treatment with linoleic acid
Schuster et al. Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3, 4-dihydroxyphenylalanine-induced dyskinesia
Dau et al. Transformation of lymphocytes from patients with multiple sclerosis: use of an encephalitogen of human origin, with a report of a trial of immunosuppressive therapy in multiple sclerosis
Xiao et al. Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia
WO1997049406A1 (en) Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction
Bergey et al. Adverse effects of phenobarbital on morphological and biochemical development of fetal mouse spinal cord neurons in culture
Flavin et al. Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons
Erringer et al. Chloroquine neuromyopathy associated with keratopathy and retinopathy.
Lagreze et al. The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro
Schneider et al. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism
US20100260755A1 (en) Ibudilast and immunomodulators combination
Sarchielli et al. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-β 1a, and high doses of immunoglobulins
Jackson et al. Role of oxidative stress in rabies virus infection of adult mouse dorsal root ganglion neurons
Di Menna et al. Fingolimod protects cultured cortical neurons against excitotoxic death
Labcharoenwongs et al. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children
Kusaka et al. An adult-onset case of sporadic motor neuron disease with basophilic inclusions
Percy et al. δ‐Aminolaevulinic Acid Uptake, Toxicity, and Effect on [14C] γ‐Aminobutyric Acid Uptake into Neurons and Glia in Culture

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15798547

Country of ref document: EP

Kind code of ref document: A1